Market Place
Sourcing Support
Ondine Commencing US Phase 3 Clinical Trial
17 Dec 2024 //
ACCESSWIRE
Ondine Continues Commercial Growth
28 Oct 2024 //
ACCESSWIRE
Ondine Biomedical Announces King`s College Hospital Steriwave Pilot
23 Oct 2024 //
ACCESSWIRE
Ondine Announces Board Changes
16 Sep 2024 //
ACCESSWIRE
Ondine Biomedical Inc Announces Corporate and Trading Update
24 Apr 2024 //
ACCESSWIRE
Ondine`s Steriwave In First Australian Hospital
22 Apr 2024 //
ACCESSWIRE
Ondine Biomedical Announces First commercial adoption of Steriwave by the NHS
25 Mar 2024 //
ACCESSWIRE
Ondine Biomedical Announces Steriwave Study Shows 77% Drop in Antibiotic Use
21 Mar 2024 //
ACCESSWIRE
Ondine Biomedical Inc. Announces Appointment of new Chief Financial Officer
16 Jan 2024 //
ACCESSWIRE
Ondine Biomedical Inc Announces C$4.91 Raise Supports Ongoing Commercialisation
12 Dec 2023 //
ACCESSWIRE
Ondine Biomedical’s photodisinfection recommended as standard of care
16 Nov 2023 //
BUSINESSWIRE
Ondine Biomedical Inc. Announces Burnaby Hospital deploys Steriwave
29 Sep 2023 //
ACCESSWIRE
Ondine Biomedical Inc. Announces Steriwave Proven Effective Against XDR Bacteria
14 Sep 2023 //
ACCESSWIRE
First NHS pilot of Ondine Biomedical’s nasal photodisinfection starts at Mid Yorkshire Teaching NHS Trust
01 Aug 2023 //
BUSINESSWIRE
Ondine Biomedical is Recipient of the TAYYABA HASAN IMPACT AWARD
17 Jul 2023 //
BUSINESSWIRE
Ondine Biomedical Appoints Senior Pharma Executive Dr. Simon Sinclair as CMO
01 Jun 2023 //
BUSINESSWIRE
Ondine Biomedical’s Nasal Photodisinfection Cuts Surgical Site Infections by 66%
18 Apr 2023 //
BUSINESSWIRE
Ondine Biomedical’s Nasal Photodisinfection Reduces Hospital Length of Stay
03 Mar 2023 //
BUSINESSWIRE
Ondine’s nasal photodisinfection therapy (APDT) improves immune response
31 Jan 2023 //
BUSINESSWIRE
Food Processing Plant Sees Huge Reduction in Employee COVID-19 Rates
08 Nov 2022 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.